Risk Recall of Complications Associated with Vestibular Schwannoma Treatment

ObjectiveTo assess the risk recall of complications among patients who underwent different vestibular schwannoma (VS) treatments.Study DesignPatients with VS completed a voluntary and anonymous survey.SettingSurvey links were distributed via the Acoustic Neuroma Association (ANA) website, Facebook, and email list.Subjects and MethodsSurveys were distributed to ANA members from January to March 2017. Of the 3200 ANA members with a VS diagnosis at the time of survey distribution, 789 (25%) completed the survey.ResultsSubjects reported the following incidence of posttreatment complications: imbalance (60%), hearing issues (51%), dry eyes (30%), headache (29%), and facial weakness (27%). Overall, 188 (25%) recalled remembering all the risks associated with their treatment. Among those in the surgical cohort (52%) who experienced balance issues, facial weakness, cerebrospinal fluid leak, meningitis, and stroke, 73%, 91%, 77%, 67%, and 33% claimed recall of these associated risks. Among those in the radiosurger...